Guangzhou Houbao Investment Partnership (Limited Partnership) signed a share transfer agreement to acquire 5.04% stake in Xiamen Amoytop Biotech Co., Ltd. (SHSE:688278) from Tonghua Dongbao Pharmaceutical Co., Ltd. (SHSE:600867) for approximately CNY 410 million on March 16, 2022. As per the transaction, Guangzhou Houbao Investment Partnership (Limited Partnership) will acquire 20.5 million shares at CNY 20.16 per share . The transaction is subject to approval by Shanghai Stock Exchange.